Efficient de novo synthesis of resveratrol by metabolically engineered Escherichia coli

Journal of Industrial Microbiology and Biotechnology

Volumn 44, Issue 7, 2017, Pages 1083-1095

  Wu, Junjun ^a,b   Zhou, Peng ^a,b   Zhang, Xia ^a,b   Dong, Mingsheng ^a,b  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Pathway optimization; Phenylpropanoids; Plant natural products; Stilbene; Synthetic biology

Indexed keywords

AMMONIA LYASE; MALONIC ACID; MALONYL COENZYME A; MESSENGER RNA; RESVERATROL; TYROSINE AMMONIA LYASE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; ESCHERICHIA COLI PROTEIN; MULTIENZYME COMPLEX; STILBENE DERIVATIVE; TYRA PROTEIN, BACTERIA;

ARTICLE; BACTERIAL GENE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CODON USAGE; CONTROLLED STUDY; DNA MODIFICATION; DOWN REGULATION; DRUG SYNTHESIS; ESCHERICHIA COLI; FATTY ACID SYNTHESIS; GENE REPRESSION; METABOLIC ENGINEERING; MICROBIAL BIOMASS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; RHIZOBIUM LEGUMINOSARUM; RNA STRUCTURE; TRICHOSPORON CUTANEUM; CHEMISTRY; CONFORMATION; CULTURE MEDIUM; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; TRANSGENIC MICROORGANISM;

BACTERIAL PROTEINS; BASE SEQUENCE; CULTURE MEDIA; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; MALONYL COENZYME A; METABOLIC ENGINEERING; MICROORGANISMS, GENETICALLY-MODIFIED; MULTIENZYME COMPLEXES; NUCLEIC ACID CONFORMATION; STILBENES;

EID: 85015798130     PISSN: 13675435     EISSN: 14765535     Source Type: Journal    
DOI: 10.1007/s10295-017-1937-9     Document Type: Article

References (35)

1. Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493–506
2. Becker J, Wittmann C (2016) Systems metabolic engineering of Escherichia coli for the heterologous production of high value molecules—a veteran at new shores. Curr Opin Biotechnol 42:178–188. doi:10.1016/j.copbio.2016.05.004
3. Cao WJ, Ma WC, Zhang BW, Wang X, Chen KQ, Li Y, Ouyang PK (2016) Improved pinocembrin production in Escherichia coli by engineering fatty acid synthesis. J Ind Microbiol Biotechnol 43:557–566. doi:10.1007/s10295-015-1725-3
4. Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci 97:6640–6645. doi:10.1073/pnas.120163297
5. Dziggel C, Schäfer H, Wink M (2017) Tools of pathway reconstruction and production of economically relevant plant secondary metabolites in recombinant microorganisms. Biotechnol J. doi:10.1002/biot.201600145
6. Ge H, Zhang J, Guo B, He Q, Wang B, He B, Wang C (2007) Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARγ. Vasc Pharmacol 46:114–121
7. Goodman DB, Church GM, Kosuri S (2013) Causes and effects of N-terminal codon bias in bacterial genes. Science 342:475–479
8. Guo HW, Madzak C, Du GC, Zhou JW, Chen J (2014) Effects of pyruvate dehydrogenase subunits overexpression on the alpha-ketoglutarate production in Yarrowia lipolytica WSH-Z06. Appl Microbiol Biotechnol 98:7003–7012. doi:10.1007/s00253-014-5745-0
9. Huang XL, Dai YQ, Cai JX, Zhong NJ, Xiao H, McClements DJ, Hu K (2017) Resveratrol encapsulation in core-shell biopolymer nanoparticles: impact on antioxidant and anticancer activities. Food Hydrocolloids 64:157–165. doi:10.1016/j.foodhyd.2016.10.029
10. Jendresen CB, Stahlhut SG, Li MJ, Gaspar P, Siedler S, Forster J, Maury J, Borodina I, Nielsen AT (2015) Highly active and specific tyrosine ammonia-lyases from diverse origins enable enhanced production of aromatic compounds in bacteria and Saccharomyces cerevisiae. Appl Environ Microbiol 81:4458–4476. doi:10.1128/aem.00405-15
11. Kikuchi Y, Tsujimoto K, Kurahashi O (1997) Mutational analysis of the feedback sites of phenylalanine-sensitive 3-deoxy-d-arabino-heptulosonate-7-phosphate synthase of Escherichia coli. Appl Environ Microbiol 63:761–762
12. Lütke-Eversloh T, Stephanopoulos G (2005) Feedback inhibition of chorismate mutase/prephenate dehydrogenase (TyrA) of Escherichia coli: generation and characterization of tyrosine-insensitive mutants. Appl Environ Microbiol 71:7224–7228. doi:10.1128/AEM.71.11.7224-7228.2005
13. Leonard E, Lim KH, Saw PN, Koffas MAG (2007) Engineering central metabolic pathways for high-level flavonoid production in Escherichia coli. Appl Environ Microbiol 73:3877–3886. doi:10.1128/AEM.00200-07
14. Leonard E, Yan Y, Fowler ZL, Li Z, Lim CG, Lim KH, Koffas MAG (2008) Strain improvement of recombinant Escherichia coli for efficient production of plant flavonoids. Mol Pharm 5:257–265. doi:10.1021/mp7001472
15. Li MJ, Kildegaard KR, Chen Y, Rodriguez A, Borodina I, Nielsen J (2015) De novo production of resveratrol from glucose or ethanol by engineered Saccharomyces cerevisiae. Metab Eng 32:1–11. doi:10.1016/j.ymben.2015.08.007
16. Liang JL, Guo LQ, Lin JF, He ZQ, Cai FJ, Chen JF (2016) A novel process for obtaining pinosylvin using combinatorial bioengineering in Escherichia coli. World J Microbiol Biotechnol 32:1–10. doi:10.1007/s11274-016-2062-z
17. Lim CG, Fowler ZL, Hueller T, Schaffer S, Koffas MAG (2011) High-yield resveratrol production in engineered Escherichia coli. Appl Environ Microbiol 77:3451–3460. doi:10.1128/AEM.02186-10
18. Liu XL, Lin J, Hu HF, Zhou B, Zhu BQ (2016) De novo biosynthesis of resveratrol by site-specific integration of heterologous genes in Escherichia coli. FEMS Microbiol Lett 363:5–18. doi:10.1093/femsle/fnw061
19. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(−Delta Delta C) method. Methods 25:402–408. doi:10.1006/meth.2001.1262
20. Mansour S, Bailly J, Delettre J, Bonnarme P (2009) A proteomic and transcriptomic view of amino acids catabolism in the yeast Yarrowia lipolytica. Proteomics 9:4714–4725. doi:10.1002/pmic.200900161
21. Nakashima N, Tamura T (2009) Conditional gene silencing of multiple genes with antisense RNAs and generation of a mutator strain of Escherichia coli. Nucleic Acids Res 37:e103
22. Neidhardt FC, Bloch PL, Smith DF (1974) Culture medium for enterobacteria. J Bacteriol 119:736–747
23. Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, Lim WA (2013) Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152:1173–1183
24. Santos CNS, Koffas MAG, Stephanopoulos G (2011) Optimization of a heterologous pathway for the production of flavonoids from glucose. Metab Eng 13:392–400. doi:10.1016/j.ymben.2011.02.002
25. Santos CNS, Xiao W, Stephanopoulos G (2012) Rational, combinatorial, and genomic approaches for engineering l-tyrosine production in Escherichia coli. Proc Natl Acad Sci 109:13538–13543. doi:10.1073/pnas.1206346109
26. van Summeren-Wesenhagen PV, Marienhagen J (2015) Metabolic engineering of Escherichia coli for the synthesis of the plant polyphenol pinosylvin. Appl Environ Microbiol 81:840–849. doi:10.1128/aem.02966-14
27. Wu JJ, Du GC, Chen J, Zhou JW (2015) Enhancing flavonoid production by systematically tuning the central metabolic pathways based on a CRISPR interference system in Escherichia coli. Sci Rep 5:14. doi:10.1038/srep13477
28. Wu JJ, Liu PR, Fan YM, Bao H, Du GC, Zhou JW, Chen J (2013) Multivariate modular metabolic engineering of Escherichia coli to produce resveratrol from l-tyrosine. J Biotechnol 167:404–411. doi:10.1016/j.jbiotec.2013.07.030
29. Wu JJ, Yu O, Du GC, Zhou JW, Chen J (2014) Fine-tuning of the fatty acid pathway by synthetic antisense RNA for enhanced (2S)-naringenin production from L-tyrosine in Escherichia coli. Appl Environ Microbiol 80:7283–7292
30. Wu JJ, Zhang X, Dong MS, Zhou JW (2016) Stepwise modular pathway engineering of Escherichia coli for efficient one-step production of (2S)-pinocembrin. J Biotechnol 231:183–192. doi:10.1016/j.jbiotec.2016.06.007
31. Wu JJ, Zhou TT, Du GC, Zhou JW, Chen J (2014) Modular optimization of heterologous pathways for de novo synthesis of (2S)-naringenin in Escherichia coli. PLoS One 9:e101492
32. Xu P, Ranganathan S, Fowler ZL, Maranas CD, Koffas MAG (2011) Genome-scale metabolic network modeling results in minimal interventions that cooperatively force carbon flux towards malonyl-CoA. Metab Eng 13:578–587. doi:10.1016/j.ymben.2011.06.008
33. Yang JE, Kim JW, Oh YH, Choi SY, Lee H, Park AR, Shin J, Park SJ, Lee SY (2016) Biosynthesis of poly(2-hydroxyisovalerate-co-lactate) by metabolically engineered Escherichia coli. Biotechnol J 11:1572–1585. doi:10.1002/biot.201600420
34. Yang YP, Lin YH, Li LY, Linhardt RJ, Yan YJ (2015) Regulating malonyl-CoA metabolism via synthetic antisense RNAs for enhanced biosynthesis of natural products. Metab Eng 29:217–226. doi:10.1016/j.ymben.2015.03.018
35. Zadeh JN, Steenberg CD, Bois JS, Wolfe BR, Pierce MB, Khan AR, Dirks RM, Pierce NA (2011) NUPACK: analysis and design of nucleic acid systems. J Comput Chem 32:170–173. doi:10.1002/jcc.21596